The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cell Viability Assays-Global Market Insights and Sales Trends 2024
Synopsis
Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment with various stimuli. Moreover, cell Viability Assays and cytotoxicity assays are used for drug screening and cytotoxicity tests of chemicals.
The global Cell Viability Assays market size is expected to reach US$ 3580.6 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Cell Viability Assays in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital and Diagnostic Laboratories and Others, are propelling Cell Viability Assays market. Human Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microbial Cells segment is estimated at % CAGR for the next seven-year period.
Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell Viability Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell Viability Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell Viability Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell Viability Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell Viability Assays covered in this report include Thermo Fisher Scientific, Merck, Bio-Rad, GE, Danaher, BD, PerkinElmer, Promega and Biotium, etc.
The global Cell Viability Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Merck
Bio-Rad
GE
Danaher
BD
PerkinElmer
Promega
Biotium
Abcam
Creative Bioarray
Biotek Instruments
Global Cell Viability Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell Viability Assays market, Segment by Type:
Human Cells
Microbial Cells
Animal Cells
Global Cell Viability Assays market, by Application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospital and Diagnostic Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell Viability Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment with various stimuli. Moreover, cell Viability Assays and cytotoxicity assays are used for drug screening and cytotoxicity tests of chemicals.
The global Cell Viability Assays market size is expected to reach US$ 3580.6 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Cell Viability Assays in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital and Diagnostic Laboratories and Others, are propelling Cell Viability Assays market. Human Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microbial Cells segment is estimated at % CAGR for the next seven-year period.
Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell Viability Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell Viability Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell Viability Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell Viability Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell Viability Assays covered in this report include Thermo Fisher Scientific, Merck, Bio-Rad, GE, Danaher, BD, PerkinElmer, Promega and Biotium, etc.
The global Cell Viability Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Merck
Bio-Rad
GE
Danaher
BD
PerkinElmer
Promega
Biotium
Abcam
Creative Bioarray
Biotek Instruments
Global Cell Viability Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell Viability Assays market, Segment by Type:
Human Cells
Microbial Cells
Animal Cells
Global Cell Viability Assays market, by Application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospital and Diagnostic Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell Viability Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cell Viability Assays
1.1 Cell Viability Assays Market Overview
1.1.1 Cell Viability Assays Product Scope
1.1.2 Cell Viability Assays Market Status and Outlook
1.2 Global Cell Viability Assays Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cell Viability Assays Market Size by Region (2018-2029)
1.4 Global Cell Viability Assays Historic Market Size by Region (2018-2023)
1.5 Global Cell Viability Assays Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cell Viability Assays Market Size (2018-2029)
1.6.1 North America Cell Viability Assays Market Size (2018-2029)
1.6.2 Europe Cell Viability Assays Market Size (2018-2029)
1.6.3 Asia-Pacific Cell Viability Assays Market Size (2018-2029)
1.6.4 Latin America Cell Viability Assays Market Size (2018-2029)
1.6.5 Middle East & Africa Cell Viability Assays Market Size (2018-2029)
2 Cell Viability Assays Market by Type
2.1 Introduction
2.1.1 Human Cells
2.1.2 Microbial Cells
2.1.3 Animal Cells
2.2 Global Cell Viability Assays Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cell Viability Assays Historic Market Size by Type (2018-2023)
2.2.2 Global Cell Viability Assays Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cell Viability Assays Revenue Breakdown by Type (2018-2029)
3 Cell Viability Assays Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Biotechnology Companies
3.1.2 Academic and Research Institutes
3.1.3 Hospital and Diagnostic Laboratories
3.1.4 Others
3.2 Global Cell Viability Assays Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cell Viability Assays Historic Market Size by Application (2018-2023)
3.2.2 Global Cell Viability Assays Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cell Viability Assays Revenue Breakdown by Application (2018-2029)
4 Cell Viability Assays Competition Analysis by Players
4.1 Global Cell Viability Assays Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2022)
4.3 Date of Key Players Enter into Cell Viability Assays Market
4.4 Global Top Players Cell Viability Assays Headquarters and Area Served
4.5 Key Players Cell Viability Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Cell Viability Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Cell Viability Assays Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Cell Viability Assays Products, Services and Solutions
5.2.4 Merck Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Bio-Rad
5.3.1 Bio-Rad Profile
5.3.2 Bio-Rad Main Business
5.3.3 Bio-Rad Cell Viability Assays Products, Services and Solutions
5.3.4 Bio-Rad Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.3.5 GE Recent Developments
5.4 GE
5.4.1 GE Profile
5.4.2 GE Main Business
5.4.3 GE Cell Viability Assays Products, Services and Solutions
5.4.4 GE Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.4.5 GE Recent Developments
5.5 Danaher
5.5.1 Danaher Profile
5.5.2 Danaher Main Business
5.5.3 Danaher Cell Viability Assays Products, Services and Solutions
5.5.4 Danaher Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.5.5 Danaher Recent Developments
5.6 BD
5.6.1 BD Profile
5.6.2 BD Main Business
5.6.3 BD Cell Viability Assays Products, Services and Solutions
5.6.4 BD Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.6.5 BD Recent Developments
5.7 PerkinElmer
5.7.1 PerkinElmer Profile
5.7.2 PerkinElmer Main Business
5.7.3 PerkinElmer Cell Viability Assays Products, Services and Solutions
5.7.4 PerkinElmer Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.7.5 PerkinElmer Recent Developments
5.8 Promega
5.8.1 Promega Profile
5.8.2 Promega Main Business
5.8.3 Promega Cell Viability Assays Products, Services and Solutions
5.8.4 Promega Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.8.5 Promega Recent Developments
5.9 Biotium
5.9.1 Biotium Profile
5.9.2 Biotium Main Business
5.9.3 Biotium Cell Viability Assays Products, Services and Solutions
5.9.4 Biotium Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.9.5 Biotium Recent Developments
5.10 Abcam
5.10.1 Abcam Profile
5.10.2 Abcam Main Business
5.10.3 Abcam Cell Viability Assays Products, Services and Solutions
5.10.4 Abcam Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.10.5 Abcam Recent Developments
5.11 Creative Bioarray
5.11.1 Creative Bioarray Profile
5.11.2 Creative Bioarray Main Business
5.11.3 Creative Bioarray Cell Viability Assays Products, Services and Solutions
5.11.4 Creative Bioarray Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.11.5 Creative Bioarray Recent Developments
5.12 Biotek Instruments
5.12.1 Biotek Instruments Profile
5.12.2 Biotek Instruments Main Business
5.12.3 Biotek Instruments Cell Viability Assays Products, Services and Solutions
5.12.4 Biotek Instruments Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.12.5 Biotek Instruments Recent Developments
6 North America
6.1 North America Cell Viability Assays Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cell Viability Assays Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell Viability Assays Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell Viability Assays Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell Viability Assays Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell Viability Assays Market Dynamics
11.1 Cell Viability Assays Industry Trends
11.2 Cell Viability Assays Market Drivers
11.3 Cell Viability Assays Market Challenges
11.4 Cell Viability Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
